Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 7c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Edwards Lifesciences (EW) Target Lifted to $94 at Jefferies Post Q1
April 25, 2014 11:17 AM EDTJefferies analyst Raj Denhoy lifted estimates and his price target on Buy-rated Edwards Lifesciences (NYSE: EW) price target of $94.00 (from $72.00) following solid Q1 results.
Denhoy SAID, "1Q TAVR upside was fueled by notable strength in Europe... More
